What are SLC1A4 antibodies?
Anti-SLC1A4 antibodies are immunoglobulins that specifically recognize and bind solute carrier family 1 member 4, a sodium-coupled neutral amino acid transporter, also known as ASCT1. These antibodies are used for immunodetection across general sample types such as tissue samples, cell lysates, and cultured cells. SLC1A4 mediates sodium-coupled exchange of neutral amino acids and has been implicated in a spastic tetraplegia neurodevelopmental disorder as well as in hepatocellular carcinoma progression.
Catalog highlights and purchasing considerations
About the Biocompare SLC1A4 antibodies catalog
The Biocompare antibody search tool lists anti-SLC1A4 antibodies from a range of suppliers, spanning polyclonal and monoclonal formats validated across multiple applications. Sample listings also reference the alternate name ASCT1. Immunohistochemistry, western blot, and ELISA are the most common validated applications among these products. In addition, the solute carrier family 1 member 4 antibodies mentioned here have been cited in research including studies on hepatocellular carcinoma progression via SLC1A4 and prostate cancer purine metabolism signaling.
Considerations when choosing a SLC1A4 antibody for research
Confirm that the antibody's intended target is accurate, as many genes carry synonym symbols that can create ambiguity across suppliers. Specificity should be verified against the immunogen sequence or region listed on the product datasheet, since antibodies raised against different epitopes of the same protein can behave differently across applications. Beyond specificity, several target-related attributes can affect antibody binding, including subcellular location, extracellular and cytoplasmic domain boundaries for membrane-associated targets, tissue specificity, post-translational modifications, and the presence of additional isoforms or disease-associated variants. In parallel, antibody-specific selection criteria include clonality (monoclonal versus polyclonal), host species, species reactivity, and the choice of conjugate or label suited to the intended detection method. Supplier-provided validation data, such as western blot bands at the expected molecular weight, immunohistochemistry staining patterns consistent with known tissue distribution, or knockout and knockdown controls, is widely regarded as the most reliable final check before purchase.